3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
40
Lymphoma, Mantle-Cell
27
Lymphoma
26
Lymphoma, Follicular
25
Lymphoma, Non-Hodgkin
23
Leukemia, Lymphocytic, Chronic, B-Cell
22
Lymphoma, B-Cell
14
Lymphoma, B-Cell, Marginal Zone
13
Burkitt Lymphoma
12
Recurrence
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Neoplasms
8
Waldenstrom Macroglobulinemia
6
Leukemia, Hairy Cell
5
Lymphoproliferative Disorders
4
Leukemia
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
beta-Thalassemia
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm, Residual
2
Lymphatic Diseases
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Biphenotypic, Acute
2
Leukemia, B-Cell
2
Infections
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Epstein-Barr Virus Infections
2
Interventions
Cyclophosphamide
5
Etoposide
3
duvelisib
2
Vincristine
2
Prednisone
2
Melphalan
2
Doxorubicin
2
Azacitidine
2
10-propargyl-10-deazaaminopterin
2
tazemetostat
1
sodium-iodide symporter
1
ruxolitinib
1
pembrolizumab
1
fludarabine phosphate
1
fludarabine
1
etoposide phosphate
1
cemiplimab
1
belinostat
1
X-Rays
1
Whole-Body Irradiation
1
Tacrolimus
1
Specimen Handling
1
Sirolimus
1
Prednisolone
1
Photons
1
Peripheral Blood Stem Cell Transplantation
1
Nivolumab
1
Mycophenolic Acid
1
Methotrexate
1
Magnetic Resonance Spectroscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoblastic Lymphadenopathy
×
Rituximab
×
90 days
×
Clear all
No trials found.